I purchased it at Milo's suggestion as well, I've not sold a share, though I don't have that big a position. If the company maintains it's current price, I suspect it will be able to move off the grey market and onto the OTC, then it will be much more visible. When Milo suggested it, he advised purchasing it as VXL on the Canadian exchange, but I purchase VXLLF through Fidelity, who assured me it was precisely the same when you convert from Canadian currency to U.S.
I believe that most of the work they do is done in Israel, I'm uncertain why they choose to put it on the Canadian exchange. I did just look it up and the site I was taken to by Fidelity for a detailed quote indicated that it's on the OTC. I'm uncertain if that's right, or if Grey quotes as OTC. I would have thought the symbol would change if moved to the OTC from the Grey's.
I saw one report indicating they intend to release further results late January, it didn't specify which product. I'm uncertain if it's Covid related, but clearly they have something which may work on Covid in addition to what they originally intended it for. The company is also working on MM and other cancers, no telling what's really working for them. I'm planning to let it ride. By far my biggest investment is in NWBO which I believe has explosive potential once they release the TLD from their Phase 3 Trial.
Hope you have a great year as well, stay healthy.
Gary
News 
Market Data 
Discover 
AI
